No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
PharmaTher Holdings Ltd: MDA AMENDED EN
PharmaTher's Sairiyo Therapeutics Gets OK to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)
PharmaTher Updated on Its Priority Original Abbreviated New Drug Application for Ketamine
PharmaTher's Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated...
PharmaTher Provides Update on Its Priority Original Abbreviated New Drug Application For Ketamine
PharmaTher Provided Update for Expected FDA Approval of Ketamine
No Data